Literature DB >> 16567958

Transcriptional regulation of megakaryopoiesis: thrombopoietin signaling and nuclear factors.

Keita Kirito1, Kenneth Kaushansky.   

Abstract

PURPOSE OF REVIEW: Thrombopoietin, the primary regulator of megakaryopoiesis, acts by modulating several nuclear transcription factors. This review focuses on recent studies that have provided new insights into the functional roles of these proteins. RECENT
FINDINGS: Among the transcription factors responsible for megakaryopoiesis, important roles for the signal transducer and activator of transcription and Forkhead box proteins have been defined. In addition, in the past several years, two new groups of transcription factors have been found to be affected by thrombopoietin signaling, homeodomain-containing HOX proteins and hypoxia-inducible factor. The HOX transcription factors, which play key roles in body pattern development, are also expressed in adult hematopoietic stem cells and play pivotal roles in their proliferation. Thrombopoietin controls the levels of expression and modifies the function of homeodomain proteins in thrombopoietin-responsive leukemic cells and in primary immature hematopoietic cells. Levels of hypoxia-inducible factor, a master transcription factor required for the adaptation to hypoxic conditions, is also affected by thrombopoietin in these cells.
SUMMARY: The discovery that a diverse range of transcription factors are downstream effectors of thrombopoietin helps to explain the molecular mechanisms by which the hormone affects hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567958     DOI: 10.1097/01.moh.0000219660.03657.4b

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  8 in total

1.  HIV-1 determinants of thrombocytopenia at the stage of CD34+ progenitor cell differentiation in vivo lie in the viral envelope gp120 V3 loop region.

Authors:  Menghua Zhang; Stella Evans; Jinyun Yuan; Lee Ratner; Prasad S Koka
Journal:  Virology       Date:  2010-03-24       Impact factor: 3.616

2.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 3.  MicroRNAs in erythroid and megakaryocytic differentiation and megakaryocyte-erythroid progenitor lineage commitment.

Authors:  L Zhang; V G Sankaran; H F Lodish
Journal:  Leukemia       Date:  2012-05-23       Impact factor: 11.528

4.  An image-based screen identifies a small molecule regulator of megakaryopoiesis.

Authors:  Anthony E Boitano; Lorenzo de Lichtervelde; Jennifer L Snead; Michael P Cooke; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

Review 5.  Platelet Versus Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?

Authors:  Cédric Garcia; Baptiste Compagnon; Michaël Poëtte; Marie-Pierre Gratacap; François-Xavier Lapébie; Sophie Voisin; Vincent Minville; Bernard Payrastre; Fanny Vardon-Bounes; Agnès Ribes
Journal:  Cells       Date:  2022-04-30       Impact factor: 7.666

Review 6.  Thrombocytosis in the NICU.

Authors:  David J Powner; W Keith Hoots
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

7.  STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice.

Authors:  Zan Huang; Terri D Richmond; Andrew G Muntean; Dwayne L Barber; Mitchell J Weiss; John D Crispino
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

8.  Cytokine-induced megakaryocytic differentiation is regulated by genome-wide loss of a uSTAT transcriptional program.

Authors:  Hyun Jung Park; Juan Li; Rebecca Hannah; Simon Biddie; Ana I Leal-Cervantes; Kristina Kirschner; David Flores Santa Cruz; Veronika Sexl; Berthold Göttgens; Anthony R Green
Journal:  EMBO J       Date:  2015-12-23       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.